New genetic test can predict man's risk of developing prostate cancer
Figure 1: Adding genotyping to PSA testing could improve prostate cancer predictions. © 2012 Brand X Pictures/Thinkstock
Researchers in Japan have created a genetic test that will help doctors diagnose prostate cancer. When given together with testing for prostate specific antigen (PSA), a widely used diagnostic biomarker for prostate cancer, the new assay could spare men from undergoing needless prostate biopsies.
"With a super-aging society coming to Japan and other Asian countries, there will be more prostate cancer patients and candidates, and more medical costs related to prostate cancer," says Hidewaki Nakagawa of the RIKEN Center for Genomic Medicine in Yokohama, who led the study. "So we have to establish 'personalized medicine' approaches to screen, diagnose, and prevent prostate diseases more precisely and more efficiently."
The genetic test includes 16 DNA markers that Nakagawa's team previously linked to prostate cancer in a 2010 study of Japanese men with the disease2. Using genetic data from around 4,000 Japanese men with prostate cancer and 7,000 healthy controls, Nakagawa and his colleagues showed that their risk assessment model was highly reproducible across cohorts and that its predictive performance was not influenced by PSA level.
To investigate whether the test might be useful to risk-stratify patients in the clinic, the researchers considered men in the so-called 'PSA gray-zone'. These men have somewhat elevated levels of PSA, yet only 20–25% of them actually have cancer. The rest typically suffer from less dangerous maladies, such as an enlarged prostate gland, and do not require aggressive treatment. Thus, doctors have long sought additional biomarkers that can identify individuals at the highest risk of prostate cancer (Fig 1.).
Nakagawa and his colleagues showed that their test could serve this purpose. Among men with gray-zone PSA scores who, the model predicted, had at least a two-fold increased chance of developing cancer, 42% had positive diagnoses. In contrast, only 11% of men who the model predicted were at low-risk had cancer, despite elevated PSA levels.
Given the complications and cost associated with the prostate needle biopsies needed to confirm the presence of cancer following a gray-zone PSA test outcome, Nakagawa suggests that only men at high genetic risk should immediately take that next step, whereas men who score low on the genetic test might choose to continue monitoring their PSA levels before resorting to a needle biopsy.
"We are now negotiating with a company and hospitals about the feasibility of the test's clinical use," Nakagawa says. "But first," he notes, "we have to get more data about its precision and cost-effectiveness in a prospective large-scale study."
More information: Akamatsu, S., Takahashi, A., Takata, R., Kubo, M., Inoue, T., Morizono, T., Tsunoda, T., Kamatani, N., Haiman, C.A., Wan, P. et al. Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese. PLoS One 7, e46454 (2012). www.plosone.org/ar… pone.0046454
Takata, R., Akamatsu, S., Kubo, M., Takahashi, A., Hosono, N., Kawaguchi, T., Tsunoda, T., Inazawa, J., Kamatani, N., Ogawa, O. et al. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nature Genetics 42, 751–754 (2010). www.nature.com/ng/… /ng.635.html
Provided by RIKEN
- PSA test valuable in predicting biopsy need, low-risk prostate cancer Oct 21, 2011 | not rated yet | 0
- PSA levels accurately predict prostate cancer risk in African-American men Feb 24, 2009 | not rated yet | 0
- PSA test for men could get a second life for breast cancer in women Jul 13, 2011 | not rated yet | 0
- New prostate cancer test gives more accurate diagnosis Apr 06, 2011 | not rated yet | 0
- Early warning: PSA testing can predict advanced prostate cancer Feb 15, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
How can there be a term called "intestinal metaplasia" of stomach
5 hours ago Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
- More from Physics Forums - Medical Sciences
More news stories
The surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient, according to a new study.
Cancer 2 hours ago | not rated yet | 0
Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients ...
Cancer 2 hours ago | not rated yet | 0
Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
Cancer 2 hours ago | 5 / 5 (1) | 0
An article published on the journal Nature describes the major role that Pyruvate dehydrogenase (PDH) —an enzyme of cellular energy metabolism— plays in the regulation of the cellular senescence induce ...
Cancer 3 hours ago | not rated yet | 0
(Medical Xpress)—Scientists at the School of Medicine have shown that their previously identified therapeutic approach to fight cancer via immune cells called macrophages also prompts the disease-fighting killer T cells ...
Cancer 4 hours ago | not rated yet | 0 |
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
44 minutes ago | not rated yet | 0 |
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
31 minutes ago | 4 / 5 (1) | 0 |
The level of immunity to the recently circulating H7N9 influenza virus in an urban and rural population in Vietnam is very low, according to the first population level study to examine human immunity to the virus, which was ...
10 minutes ago | not rated yet | 0 |
Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...
7 minutes ago | not rated yet | 0 |
In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding ...
22 minutes ago | not rated yet | 0 |
Prostaglandin analogues (PGAs), drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks. PGAs have long been associated with blurred vision, ...
9 minutes ago | not rated yet | 0